Guidelines
Education & Events
Event calendar
Join our events
On-demand education
Learn at your own pace
Scholarships
Enrich your capabilities
Exchange Programmes
Urology beyond Europe
Education
Educational Platforms
Talent Incubator Programme
Accreditation
Science & Publications
Publications
Our publications
Research & Science
Passionate about research?
About
Who we are
Our mission and history
Our Board and Offices
How we work
Join the EAU
Find out about membership
Vacancies
Contact
On-demand education
Kidney Cancer
Andrology
Bladder Cancer
Female Urology
Functional Urology
Infections
Kidney Cancer
LUTS
Oncology
Paediatric Urology
Prostate Cancer
Rare cancers
Reconstructive Urology
Technology
Transplantation
Trauma
Urolithiasis
No elements found. Consider changing the search query.
List is empty.
Type
E-course
Podcast
Recorded Webinar
Surgical Education
No elements found. Consider changing the search query.
List is empty.
ASCO2024 special: Circulating kidney injury molecule-1 biomarker analysis in IMmotion010
Duration: Approx. 15 min
Special series on RCC: Beyond first-line treatment strategies for mRCC with Dr. Mari and Dr. Ciccarese
Duration: Approx. 13 minutes
Special series on RCC: First-line treatment strategies for mRCC with Dr. Mari and Dr. Marandino
Duration: Approx. 14 minutes
Role of cytoreductive nephrectomy for mRCC with Assist. Prof. Mari and Prof. Badani
Duration: Approx. 15 minutes
ASCO GU24 special: Prof. Michael Hofman talks about a novel CA IX-targeting peptide
Duration: Approx. 7 minutes
ASCO GU24 special: Prof. Nizar Tannir shares CheckMate 214 results
Duration: Approx. 13 minutes
ASCO GU24 special: Assoc. Prof. Barata discusses the results of KEYNOTE-564 and CheckMate-914
Duration: Approx. 11 minutes
UROONCO RCC take home message for 2023
Duration: Approx. 18 minutes
Dr. Agarwal shares LITESPARK-013 results: Optimal dose of belzutifan is 120mg
Duration: Approx. 4 minutes
Prof. Roberto Iacovelli: Drug interruptions in mRCC IO-TKI (Avelumab and axitinib) is safe and may reduce toxicity and cost for the treatment
Duration: Approx. 6 minutes
Prof. Albiges shares LITESPARK-005 study results: Belzutifan improves PFS in pretreated mRCC patients
Duration: Approx. 5 minutes
Special series: 3D models for kidney cancer with caval thrombous
Duration: Approx. 12 minutes
Recording: Impact of ERAS in Kidney cancer
Duration: Approx. 80 minutes
Special series: Vascular perfusion 3D models and augmented reality for RCC surgery
Duration: Approx. 19 minutes
Discussion with Prof. Badani at ERUS23 on RAPN
Duration: Approx 8 minutes
Prof. Kaouk talks about the novel single-port robotic platform
Duration: Approx. 7min
Page
1
Page
2